Enlivex Ltd (ENLV) Historical Volatility

Tracking ENLV historical volatility helps you see how much Enlivex Ltd's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, Enlivex Ltd's HV tells you what really happened. Use our scanner to monitor ENLV 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.

Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The ENLV 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing Enlivex Ltd's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.

Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Nes Ziona, Israel.

Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts Enlivex Ltd's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where ENLV HV is running hot, cold, or in line. Make the ENLV 30 day historical volatility — and every other window — work for your edge instead of against it.